Both of these models are widely used and represent the two main etiologies of HER2-positive breast cancer in humans: constitutively active HER2 (ErbB2 mice32) and amplified wild-type HER2 (Neu mice31), which is found in the majority of human cases2–4. This evidence concerns the gene ERBB2 and breast carcinoma.